Feds Ask Judges to Follow Judge in Lilly Case and Validate HRSA’s Take on 340B Contract Pharmacy

DOJ has asked judges in five manufacturers' 340B contract pharmacy cases to follow to follow the lead of the judge in Lilly’s case and hold that these five companies’ contract pharmacy policies are illegal.

The federal government on Tuesday urged the judges in AstraZeneca, Novartis, Novo Nordisk, Sanofi, and United Therapeutics’ separate 340B contract pharmacy lawsuits to follow the lead of the judge in Lilly’s case and hold that these five companies’ contract pharmacy

Read More »

Biden Taps Judge in AstraZeneca’s 340B Lawsuit for Appeals Court Seat

Leonard Stark, the federal district judge assigned to AstraZeneca’s 340B contract pharmacy lawsuit, was nominated yesterday to fill a vacancy on a federal appeals court in Washington, D.C.

President Biden yesterday nominated the federal district judge assigned to AstraZeneca’s 340B contract pharmacy lawsuit to fill a vacancy on a federal appeals court in Washington, D.C.

The White House announced U.S. District Judge Leonard Stark’s nomination to be a

Read More »

Kalderos Tells Hospitals its Service to Turn 340B Discounts into Rebates is Operational

A screenshot of drug industry vendor Kalderos' email announcement this week that 340B Pay, its service to let drug companies pay 340B ceiling prices as rebates instead of as discounts, is operational.

Drug discount management company Kalderos sent email messages to 340B hospitals this week once again announcing the launch of its 340B Pay service to let drug companies pay 340B ceiling prices as back-end rebates instead of as front-end discounts on

Read More »

News Alert: CMS Will Continue Deep Cut in 340B Hospitals’ Medicare Part B Drug Reimbursement

CMS in 2022 will continue a nearly 30% reduction in place since 2018 in Medicare Part B reimbursement for many hospitals’ 340B-purchased drugs and biologicals.

In a big disappointment for 340B hospital organizations, the U.S. Centers for Medicare & Medicaid Services (CMS) announced late this afternoon that it will continue a nearly 30% reduction in place since 2018 in Medicare Part B reimbursement for hospitals’

Read More »

340B Stakeholders Size Up Friday’s Mixed Decision in Lilly’s 340B Contract Pharmacy Lawsuit

Both sides are claiming victory after Federal Judge Sarah Evans Barker’s ruling Friday in Eli Lilly’s lawsuit against HHS and HRSA.

Both sides are claiming victory after a federal judge’s ruling Friday in Eli Lilly’s lawsuit against federal health agencies in defense of its policies on 340B pricing when covered entities use contract pharmacies.

U.S. Senior Judge’s Sarah Evans Barker

Read More »

CMS Decision on Whether to Keep Part B Drug Payment Cuts for 340B Hospitals Could Come as Soon as Today

CMS could disclose as soon as today whether it will continue, end, or modify its nearly 30% cut in certain hospitals’ Medicare Part B reimbursement for 340B-purchased drugs.

The U.S. Centers for Medicare & Medicaid Services (CMS) could disclose as soon as today whether it will continue, end, or modify the nearly 30% cut in certain hospitals’ Medicare Part B reimbursement for 340B-purchased drugs.

The White House Office

Read More »

Grassley Asks HHS General Counsel Nominee About Drug Companies “Harming Access” to 340B

HHS General Counsel nominee Sam Bagenstos answered questions about the 340B program during his Oct. 26 Senate Finance confirmation hearing.

A GOP U.S. Senator who has been active on 340B matters for decades last week asked President Biden’s pick to be the U.S. Health and Human Services Department’s top lawyer if HHS could be doing more to protect the 340B

Read More »

Democrats Still Trying to Make a Deal on Federal Drug Pricing Legislation

Congressional Democrats and the White House reportedly are still trying to strike a deal on federal drug pricing legislation.

Efforts to pass federal drug pricing legislation, pronounced dead by many last week, arose in time for Halloween.

Liberal and conservative congressional Democrats and the White House reportedly are still trying to strike a deal centered on letting Medicare negotiate

Read More »

Biden Administration Wants to Scuttle Azar’s Rule to Automatically Snuff Out HHS Regulations

The Biden administration says it wants to withdraw or repeal ex-HHS Secretary Alex Azar’s final rule that will automatically extinguish all HHS regulations if HHS does not renew each regulation within a certain timeframe. | C-SPAN

The Biden administration last Friday, as widely expected, proposed withdrawing or repealing a Trump administration final rule that will automatically extinguish all U.S. Health and Human Services (HHS) regulations if HHS does not renew each regulation within a certain timeframe.

Read More »

Breaking News

Breaking: Federal Judge Vacates HRSA’s May 17 Letter to Lilly on 340B Contract Pharmacies, Sends Matter Back to Agency

A federal district judge late this afternoon struck down, as arbitrary and capricious, HRSA's finding that Lilly's 340B contract pharmacy policies violate the 340B statute. However, the judge said that manufacturers should not be allowed to unilaterally impose conditions on the location and delivery of 340B drugs and sent the matter back to HRSA.

A federal district judge in Indianapolis late this afternoon set aside and vacated the federal government’s May 17 finding that drug manufacturer Eli Lilly’s denials of 340B ceiling prices when covered entities use contract pharmacies violate the 340B statute.

A

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live